| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2002 | EP0906262B1 Colchicine-skeleton compounds, their use as medicaments and compositions containing them |
| 08/14/2002 | EP0861068B1 Method and device for producing a parenteral medicament |
| 08/14/2002 | EP0857718B1 Endothelin antagonist |
| 08/14/2002 | EP0820520B1 Improved enzymatic synthesis of oligosaccharides |
| 08/14/2002 | EP0814823B1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0806964B1 Chemical compounds |
| 08/14/2002 | EP0800399B1 Combined therapeutical treatment of hyperproliferative diseases |
| 08/14/2002 | EP0794772B1 Medicaments for enhancing outflow of aqueous humor in treatment of glaucoma |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0764443B1 Products for the treatment of cachexia associated with tumors |
| 08/14/2002 | EP0759920B1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands |
| 08/14/2002 | EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | EP0703916B1 14-substituted marcfortines and derivatives useful as antiparasitic agents |
| 08/14/2002 | EP0701448B1 Amplification of the vitamin b 12 uptake system using polymers |
| 08/14/2002 | EP0672193B1 Use of oligonucleotides having a conserved g 4 core sequence for the preparation of a medicament |
| 08/14/2002 | EP0535034B1 Pharmaceutically active benzoquinazoline compounds |
| 08/14/2002 | DE10158523A1 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue |
| 08/14/2002 | DE10106214A1 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz New alkyl-phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 08/14/2002 | DE10105989A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 08/14/2002 | DE10105308A1 Sorbinsäure als wachstumsstabilisierender Zusatz zu Futtermitteln für die Nutztieraufzucht Sorbic acid as an additive to wachstumsstabilisierender feed for livestock production |
| 08/14/2002 | DE10104895A1 Verwendung von 3-(2-Mercaptoethyl)-1-methylchinazolin-2,4(1H,3H)-dion als Inhibitor für humane Phosphodiesterasen Using 3- (2-mercaptoethyl) -1-methylquinazolin-2,4 (1H, 3H) -dione as an inhibitor of human phosphodiesterases |
| 08/14/2002 | DE10104055A1 Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren Use of carbohydrates on the Elimination of intestinal infections in animals |
| 08/14/2002 | DE10103860A1 Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung Transdermal therapeutic system for the administration of carboxyl-containing, non-steroidal anti-inflammatory agents, and to processes for its preparation |
| 08/14/2002 | DE10103565A1 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 08/14/2002 | DE10103506A1 Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose A pharmaceutical composition for the treatment of Multiple Sclerosis |
| 08/14/2002 | DE10061138C1 Pharmazeutische Zubereitung in Form eines Saftes enthaltend einen säurelabilen Wirkstoff A pharmaceutical composition in the form of a juice containing an acid-labile drug |
| 08/14/2002 | CN1364170A Thiophene A2A receptor agaonists |
| 08/14/2002 | CN1364168A Hydrochloride of fused-heterocycle compound |
| 08/14/2002 | CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364158A Mutilin derivatives and their use as antibacterials |
| 08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
| 08/14/2002 | CN1364156A Novel naphthalene ureas as glucose uptake enhancers |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364092A Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 08/14/2002 | CN1364090A Medicinal compositions containing anti-Fas antibody |
| 08/14/2002 | CN1364087A Methods of treatment and drug screening methods |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364084A Method of inducing cancer cell death and tumor regression |
| 08/14/2002 | CN1364083A Transdermal composition of antivomiting agent and preparation containing the same |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1364081A 2-aminotetralin derivatives for therapy of glaucoma |
| 08/14/2002 | CN1364080A Th2 differentiation inhibitors |
| 08/14/2002 | CN1364079A Transnasal anticonvulsive compositions and modulated process |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/14/2002 | CN1364076A Oral form of administration containing probiotic micro-organisms |
| 08/14/2002 | CN1364075A Ambroxol-containing lozenge |
| 08/14/2002 | CN1364073A Skin care composition for mediating cell to cell communication |
| 08/14/2002 | CN1364056A Pyrithione biocides enhanced by silver, copper, or zinc ions |
| 08/14/2002 | CN1363611A Extracting process and application of polygonapolyose |
| 08/14/2002 | CN1363394A Process for preparing nano particles of hydroxycamptothecine polylactate |
| 08/14/2002 | CN1363393A Process for preparing health-care compound sheep placenta extract food series |
| 08/14/2002 | CN1363381A Composition for increasing egg-laying rate of hen |
| 08/14/2002 | CN1363377A Medicine for treating cold |
| 08/14/2002 | CN1363361A Fast-acting Shengji San |
| 08/14/2002 | CN1363352A Chuqin Zihou San and its preparing process |
| 08/14/2002 | CN1363319A Medicine and method for treating psoriasis |
| 08/14/2002 | CN1363281A Application of carboxymethyl chitosan in treating gastritis and gastric ulcer |
| 08/14/2002 | CN1363280A Composition for preventing and treating enterotoxic syndrome of meat chicken |
| 08/14/2002 | CN1363279A Compound roxithromycin suppository |
| 08/14/2002 | CN1363278A Itch-tinea mixture |
| 08/14/2002 | CN1363277A Freeze-dried powder injection and its preparing process |
| 08/14/2002 | CN1363276A Exterior-applied medicine 'Shufushan' for treating dermatopathy |
| 08/14/2002 | CN1363275A Application of paralytic PSP toxin in preparing antalgesic medicine |
| 08/14/2002 | CN1363274A Application of ligustrazine and aminoguanidin in treating II-type diabetes and its complication |
| 08/14/2002 | CN1363273A Medicine for treating vascular endotheliocyte disfunction type cardiovascular disease |
| 08/14/2002 | CN1089092C Deterpene-kind compound anticancer drug capable of promoting differentiation and depressing proliferation and preparation method and use thereof |
| 08/14/2002 | CN1089001C Itching-stopping chili liquid and its preparation |
| 08/14/2002 | CN1088996C Compounded Chinese medical cream for curing scars |
| 08/14/2002 | CN1088994C Medicinal composition for treating foot ringworm |
| 08/14/2002 | CN1088993C Long-acting subcutaneous contraceptive implanting agent containing pregnadienone |
| 08/14/2002 | CN1088992C Topically administrable compositions containing 2-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 08/14/2002 | CN1088991C Remedy for ischemic diseases |
| 08/14/2002 | CA2371487A1 Tricyclic sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/13/2002 | US6433343 Device and method for photoactivation |
| 08/13/2002 | US6433225 Process for the preparation of fluvoxazmine maleate |
| 08/13/2002 | US6433202 Antiinflammatory agents |
| 08/13/2002 | US6433197 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 08/13/2002 | US6433187 Certain polycyclic compounds useful as tubulin-binding agents |
| 08/13/2002 | US6433183 (R)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,6-dihydroimidazo[1,2-a]imidazole-2,5-dione |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433180 Carboxylic acids for synthesis of taxane derivatives |
| 08/13/2002 | US6433179 Process for producing paroxetine |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof |
| 08/13/2002 | US6433152 Sophoroselipids, method for their production and use |
| 08/13/2002 | US6433151 Erythromycin derivatives, a process for their preparation and their use as medicaments |
| 08/13/2002 | US6433150 Antitumor agents |
| 08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 08/13/2002 | US6433027 Medicament compositions based on tiotropium bromide and formoterol fumarate |
| 08/13/2002 | US6433026 Process for removing bile salts from a patient and alkylated compositions therefor |